Oncology Today with Dr Neil Love cover image

Special Edition — Key Presentations from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting, Ovarian Cancer Issue

Oncology Today with Dr Neil Love

00:00

The Primary Maintenance Issue in Ovarian Cancer

The only debate in my mind is should you add BAB to that, like the Powell One Regiment. So if I have a patient who's on BAB and I find their Braca positive, I continue to laparip. Single agent, parpen inhibitor maintenance, absolutely 100%, is the standard of care.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app